Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies

View source ↗

Summary

BioSensics is conducting a digital health technology trial for Progressive Supranuclear Palsy and Dementia with Lewy Bodies, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: BioSensics | Conditions: Progressive Supranuclear Palsy(PSP), Dementia With Lewy Bodies (DLB) | Status: NOT_YET_RECRUITING